Aurora Cannabis Inc. Logo

Aurora Cannabis Inc.

21P1.F

(1.2)
Stock Price

0,36 EUR

-69.94% ROA

-129.98% ROE

-0.22x PER

Market Cap.

29.432.354,30 EUR

58.51% DER

0% Yield

-456.34% NPM

Aurora Cannabis Inc. Stock Analysis

Aurora Cannabis Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Aurora Cannabis Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.42x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (33%), which means it has a small amount of debt compared to the ownership it holds

3 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

4 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

5 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

6 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-2) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

7 ROE

The stock's ROE indicates a negative return (-27.99%) on shareholders' equity, suggesting poor financial performance.

8 ROA

The stock's ROA (-19.28%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

9 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

11 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

Aurora Cannabis Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Aurora Cannabis Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Hold

Aurora Cannabis Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Aurora Cannabis Inc. Revenue
Year Revenue Growth
2007 0
2008 0 0%
2009 40.834 100%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 1.439.271 100%
2017 18.067.000 92.03%
2018 55.196.000 67.27%
2019 245.536.000 77.52%
2020 247.939.000 0.97%
2021 278.906.000 11.1%
2022 245.252.000 -13.72%
2023 197.052.000 -24.46%
2023 161.157.000 -22.27%
2024 197.052.000 18.22%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Aurora Cannabis Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 432.384 100%
2016 565.140 23.49%
2017 314.000 -79.98%
2018 1.679.000 81.3%
2019 14.778.000 88.64%
2020 14.778.000 0%
2021 26.070.000 43.31%
2022 11.447.000 -127.75%
2023 6.412.000 -78.52%
2023 5.346.000 -19.94%
2024 6.412.000 16.63%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Aurora Cannabis Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 0
2008 0 0%
2009 185.349 100%
2010 49.986 -270.8%
2011 181.955 72.53%
2012 250.022 27.22%
2013 152.642 -63.8%
2014 280.666 45.61%
2015 2.608.189 89.24%
2016 3.928.197 33.6%
2017 14.397.000 72.72%
2018 80.415.000 82.1%
2019 266.108.000 69.78%
2020 279.404.000 4.76%
2021 265.175.000 -5.37%
2022 139.680.000 -89.84%
2023 128.944.000 -8.33%
2023 97.614.000 -32.1%
2024 128.944.000 24.3%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Aurora Cannabis Inc. EBITDA
Year EBITDA Growth
2007 -1.246
2008 -228.557 99.45%
2009 -144.515 -58.15%
2010 -57.184 -152.72%
2011 -185.362 69.15%
2012 -330.363 43.89%
2013 -402.446 17.91%
2014 -298.327 -34.9%
2015 -9.241.522 96.77%
2016 -4.749.090 -94.6%
2017 -12.983.000 63.42%
2018 -78.456.000 83.45%
2019 -218.700.000 64.13%
2020 -214.662.000 -1.88%
2021 -393.231.000 45.41%
2022 -137.200.000 -186.61%
2023 -153.356.000 10.53%
2023 -135.758.000 -12.96%
2024 -153.356.000 11.48%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Aurora Cannabis Inc. Gross Profit
Year Gross Profit Growth
2007 0
2008 0 0%
2009 40.834 100%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 2.202.236 100%
2017 16.056.000 86.28%
2018 43.519.000 63.11%
2019 142.440.000 69.45%
2020 159.815.000 10.87%
2021 -33.539.000 576.5%
2022 -21.558.000 -55.58%
2023 -6.832.000 -215.54%
2023 -13.488.000 49.35%
2024 -6.832.000 -97.42%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Aurora Cannabis Inc. Net Profit
Year Net Profit Growth
2007 1.267
2008 -177.286 100.71%
2009 -145.659 -21.71%
2010 -43.906 -231.75%
2011 -322.497 86.39%
2012 -315.760 -2.13%
2013 -393.489 19.75%
2014 -399.705 1.56%
2015 -9.518.369 95.8%
2016 -5.723.506 -66.3%
2017 -12.968.000 55.86%
2018 71.936.000 118.03%
2019 -293.509.000 124.51%
2020 -290.837.000 -0.92%
2021 -3.310.337.000 91.21%
2022 -693.625.000 -377.25%
2023 -206.416.000 -236.03%
2023 -735.418.000 71.93%
2024 -206.416.000 -256.28%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Aurora Cannabis Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 -1 100%
2016 -1 0%
2017 -1 0%
2018 2 100%
2019 -4 133.33%
2020 -4 0%
2021 -34 90.91%
2022 -4 -725%
2023 -1 0%
2023 0 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Aurora Cannabis Inc. Free Cashflow
Year Free Cashflow Growth
2007 15.114
2008 -90.525 116.7%
2009 -39.037 -131.9%
2010 -64.772 39.73%
2011 -275.478 76.49%
2012 -278.889 1.22%
2013 -447.844 37.73%
2014 -139.794 -220.36%
2015 -11.157.790 98.75%
2016 -8.656.312 -28.9%
2017 -36.224.000 76.1%
2018 -218.612.000 83.43%
2019 -606.435.000 63.95%
2020 -606.543.000 0.02%
2021 -692.958.000 12.47%
2022 -142.051.000 -387.82%
2023 -36.693.000 -287.13%
2024 -36.693.000 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Aurora Cannabis Inc. Operating Cashflow
Year Operating Cashflow Growth
2007 15.114
2008 -87.256 117.32%
2009 -39.037 -123.52%
2010 -3.084 -1165.79%
2011 -180.910 98.3%
2012 -277.979 34.92%
2013 -447.844 37.93%
2014 -139.794 -220.36%
2015 -3.324.178 95.79%
2016 -6.771.479 50.91%
2017 -10.506.000 35.55%
2018 -81.667.000 87.14%
2019 -192.245.000 57.52%
2020 -192.245.000 0%
2021 -337.952.000 43.11%
2022 -109.838.000 -207.68%
2023 -31.138.000 -252.75%
2024 -31.138.000 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Aurora Cannabis Inc. Capital Expenditure
Year Capital Expenditure Growth
2007 0
2008 3.269 100%
2009 0 0%
2010 61.688 100%
2011 94.568 34.77%
2012 910 -10292.09%
2013 0 0%
2014 0 0%
2015 7.833.612 100%
2016 1.884.833 -315.61%
2017 25.718.000 92.67%
2018 136.945.000 81.22%
2019 414.190.000 66.94%
2020 414.298.000 0.03%
2021 355.006.000 -16.7%
2022 32.213.000 -1002.06%
2023 5.555.000 -479.89%
2024 5.555.000 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Aurora Cannabis Inc. Equity
Year Equity Growth
2007 430.222
2008 1.685.259 74.47%
2009 1.619.087 -4.09%
2010 1.714.212 5.55%
2011 1.372.626 -24.89%
2012 1.074.552 -27.74%
2013 694.200 -54.79%
2014 1.353.361 48.71%
2015 3.832.810 64.69%
2016 5.962.170 35.71%
2017 218.933.000 97.28%
2018 1.563.131.000 85.99%
2019 4.387.374.000 64.37%
2020 4.390.047.000 0.06%
2021 2.126.450.000 -106.45%
2022 662.354.000 -221.04%
2023 594.497.000 -11.41%
2024 594.497.000 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Aurora Cannabis Inc. Assets
Year Assets Growth
2007 445.062
2008 1.691.834 73.69%
2009 1.627.417 -3.96%
2010 1.729.534 5.9%
2011 1.388.069 -24.6%
2012 1.121.220 -23.8%
2013 718.545 -56.04%
2014 1.887.349 61.93%
2015 13.526.622 86.05%
2016 18.396.545 26.47%
2017 322.679.000 94.3%
2018 1.910.716.000 83.11%
2019 5.499.241.000 65.25%
2020 5.502.830.000 0.07%
2021 2.783.695.000 -97.68%
2022 1.084.356.000 -156.71%
2023 1.169.927.000 7.31%
2024 1.169.927.000 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Aurora Cannabis Inc. Liabilities
Year Liabilities Growth
2007 14.840
2008 6.575 -125.7%
2009 8.330 21.07%
2010 15.322 45.63%
2011 15.443 0.78%
2012 46.668 66.91%
2013 24.345 -91.69%
2014 533.988 95.44%
2015 9.693.812 94.49%
2016 12.434.375 22.04%
2017 103.746.000 88.01%
2018 347.585.000 70.15%
2019 1.111.867.000 68.74%
2020 1.112.783.000 0.08%
2021 657.245.000 -69.31%
2022 422.002.000 -55.74%
2023 575.430.000 26.66%
2024 575.430.000 0%

Aurora Cannabis Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.54
Net Income per Share
-2.45
Price to Earning Ratio
-0.22x
Price To Sales Ratio
0.18x
POCF Ratio
-1.37
PFCF Ratio
-0.22
Price to Book Ratio
0.29
EV to Sales
-0.09
EV Over EBITDA
0.09
EV to Operating CashFlow
0.12
EV to FreeCashFlow
0.1
Earnings Yield
-4.54
FreeCashFlow Yield
-4.62
Market Cap
0,03 Bil.
Enterprise Value
-0,01 Bil.
Graham Number
10.1
Graham NetNet
-0.33

Income Statement Metrics

Net Income per Share
-2.45
Income Quality
0.16
ROE
-1.3
Return On Assets
-0.63
Return On Capital Employed
-0.19
Net Income per EBT
0.98
EBT Per Ebit
3.97
Ebit per Revenue
-1.17
Effective Tax Rate
0.02

Margins

Sales, General, & Administrative to Revenue
0.61
Research & Developement to Revenue
0.03
Stock Based Compensation to Revenue
0.07
Gross Profit Margin
-0.08
Operating Profit Margin
-1.17
Pretax Profit Margin
-4.66
Net Profit Margin
-4.56

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.39
Free CashFlow per Share
-0.45
Capex to Operating CashFlow
0.15
Capex to Revenue
-0.11
Capex to Depreciation
-0.41
Return on Invested Capital
-0.21
Return on Tangible Assets
-0.7
Days Sales Outstanding
104.05
Days Payables Outstanding
38.05
Days of Inventory on Hand
305.64
Receivables Turnover
3.51
Payables Turnover
9.59
Inventory Turnover
1.19
Capex per Share
-0.06

Balance Sheet

Cash per Share
1,23
Book Value per Share
1,85
Tangible Book Value per Share
1.58
Shareholders Equity per Share
1.85
Interest Debt per Share
1.2
Debt to Equity
0.59
Debt to Assets
0.28
Net Debt to EBITDA
0.28
Current Ratio
4.07
Tangible Asset Value
0,48 Bil.
Net Current Asset Value
0,11 Bil.
Invested Capital
0.59
Working Capital
0,51 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,05 Bil.
Average Payables
0,02 Bil.
Average Inventory
143083500
Debt to Market Cap
11.06

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Aurora Cannabis Inc. Dividends
Year Dividends Growth

Aurora Cannabis Inc. Profile

About Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

CEO
Mr. Miguel Martin
Employee
1.130
Address
500 - 10355 Jasper Avenue
Edmonton, T5J 1Y6

Aurora Cannabis Inc. Executives & BODs

Aurora Cannabis Inc. Executives & BODs
# Name Age
1 Mr. Alex Miller
Executive Vice President of Operations & Supply Chain
70
2 Dr. Jonathan Page Ph.D.
Senior Science Advisor
70
3 Mr. Rick Savone
Senior Vice President of Global Government Relations
70
4 Mr. Andre Jerome
Executive Vice President of Global Business Development
70
5 Mr. Glen Ibbott
Chief Financial Officer
70
6 Mr. Miguel Martin
Chief Executive Officer & Director
70
7 Michelle Lefler
Vice President of Communications & Public Relations
70
8 Ms. Lori Schick
Executive Vice President of Human Resources
70
9 Ananth Krishnan
Vice President of Capital Markets & Investor Relations
70
10 Ms. Nathalie Clark
Executive Vice President, General Counsel & Corporate Secretary
70

Aurora Cannabis Inc. Competitors